Skip to main content
. Author manuscript; available in PMC: 2020 Mar 1.
Published in final edited form as: Pediatr Diabetes. 2018 Dec 27;20(2):172–179. doi: 10.1111/pedi.12809

Table 1:

Characteristics of youth with type 1 diabetes at baseline SEARCH visit, according to DKA status at diagnosis

Variable Missing DKA
(n=397)
No DKA
(n=999)
p-value

Age at diagnosis (years) 0 (0%) 9.3 ± 3.9 9.4 ± 4.1 0.75
Sex (female) 0 (0%) 198 (50%) 471 (47%) 0.36
Race/Ethnicity 0 (0%) 0.005
 Non-Hispanic white 287 (72%) 802 (80%)
 Non-Hispanic black 46 (12%) 86 (9%)
 Hispanic 50 (12%) 96 (10%)
 Other 14 (4%) 15 (1%)
Household Income 94 (7%) <.0001
 <$25K 64 (18%) 121 (13%)
 $25-49K 108 (30%) 185 (20%)
 $50-74K 67 (18%) 212 (22%)
 $75K+ 124 (34%) 421 (45%)
Health Insurance Status 10 (1%) 0.001
 Private 291 (74%) 822 (82%)
 Medicaid/Medicare 82 (21%) 148 (15%)
 Self-pay 11 (3%) 9 (1%)
 Other 7 (2%) 16 (2%)
Insulin Regimen 59 (4%) 0.17
 Injectable Insulin 353 (93%) 867 (90%)
 Pump 26 (7%) 91 (10%)
Frequency of Glucose Monitoring 59 (4%) 0.08
 4 or more times a day 329 (86%) 845 (88%)
 1-3 times a day 45 (12%) 108 (11%)
 Less than once a day 6 (2%) 4 (1%)
Duration of diabetes at baseline (months) 0 (0%) 9.7 ± 6.1 9.0 ± 6.2  0.05
Fasting C-peptide (ng/mL)a 14 (1%) 0.4 (0.2-0.9) 0.5 (0.2-1.0) 0.03
Baseline HbA1c (%) 7 (0.5%) 9.9 ± 1.5 8.5 ± 1.4 <.0001
Number of HbA1c measures over time 3.3 ± 1.0 3.4 ± 1.1 0.26
Follow-up time (months of diabetes duration) 97.1 ± 29.6 97.0 ± 29.7 0.98

Data are presented as mean ± SD and comparisons made using the unpaired Students t-test.

Categorical data are presented as number (%) and comparisons made using a chi-square test.

aData are presented as median (IQR) comparisons made using the Wilcoxon rank-sum test.

DKA = diabetic ketoacidosis. HbA1c = hemoglobin A1c